Today an updated version of the Investment Gallery of the Dynamic Dashboard was released. This new version has incorporated suggestions received and aims to increase the functionality and utility of the Investment Gallery based on feedback.
Key changes include:
- A search function and the ability to export results in an excel spreadsheet
- Providing abstracts and other project level information where possible
- Refining the structure of the gallery so that each One Health sector can have a dedicated area that provides information relevant only to that sector
- Changes to make it easier to understand what is presented
- Making our key supporting documents, like the definitions for the categories and our data sources, much easier to find and more user friendly, and
- Changing some of the visuals so that the information presented is more targeted to user needs.
More is yet to come for the Investment Gallery, and we are still working on presenting information on the research organisations and also developing key messages and data trends.
In addition, stay tuned for the launch of projects and investments on animal health R&D on 31 July 2020 and the two new Galleries, Pipeline and Incentives, in August 2020.
It is our great pleasure to welcome the African Association for Research and Control of AMR (AAAMR), AdvaMedDx, UNITAID and the World Farming Organization (WFO) as additional members of the Stakeholder Group that now consists of 20 members representing organisations from NGOs/civil society, industry, international research-funding initiatives and academia.
We are particularly excited as with the support of the new members we are achieving broader technical and geographic coverage that strengthens our work and help us realize our strategic goals.
AAAMR is composed of African experts and scientist in the fields of Bacteriology, Mycology, Parasitology and Virology that focus on AMR issues on the African continent encompassing all One Health sectors. AdvaMedDx is the world’s largest trade association representing medical diagnostics manufacturer and advocates for the power of innovative medical diagnostic tests and technologies that facilitate evidence-based medicine, enable early detection of disease, enhance patient health, and advance public health and have committed on diagnostics tests to fight AMR. The member-based association WFO brings together national farmers’ organizations and agricultural cooperatives from all over the world. As highlighted in their 2019 published ‘Policy on AMR use and resistance in livestock’ the importance of investments in research of new medicine and alternatives to medicine to treat animals in an effective way is well-aligned with the work of the Hub. And the international organization UNITAID which invests in innovations to prevent, diagnose and treat HIV/AIDS, tuberculosis and malaria more quickly, affordably and effectively and also works on improving access to diagnostics and treatment for HIV co-infections such as hepatitis C and human papillomavirus (HPV).
The Stakeholder Group was established in early 2019 to provide input to our work and are offering a voice of the different needs in the field of AMR R&D considering all One Health sectors. We are grateful for the members valuable contributions that have helped advancing the development of the Dynamic Dashboard and other areas of our work and we are looking forward to our continued collaboration.
Two years have passed since the Global AMR R&D Hub was launched in May 2018. During this time, the global partnership has expanded and the work of the Hub has progressed under three strategic pillars. Read more here..
On May 27 – 29, 2020 the Secretariat of the Global AMR R&D Hub participated in the One Health EJP Annual Scientific Meeting 2020 online event (https://www.ohejp2020.com/), where foodborne zoonoses, antimicrobial resistance and emerging threats were discussed.
Dr Ralf Sudbrak, Scientific Programme Officer at the Hub, gave a presentation titled “The Dynamic Dashboard of the Global AMR R&D Hub”, highlighting the importance of information sharing, by introducing the newly launched AMR dashboard as a new tool for knowledge brokering.
In May the Global AMR R&D Hub called for tenders for the implementation of a study to determine the global market potentials for four prioritised products relevant for addressing AMR. The call closed on June 19, 2020.
It is encouraging to see the level of current investment and its breadth. With the continuing rise of antimicrobial resistance and implications cutting across all areas of medicine, investments are a necessary foundation for urgently needed progress. The Dynamic Dashboard will help funders in their future funding decisions. Some high-level summary of information from the Dynamic Dashboard can be found here.
31 March 2020: The link to the Dynamic Dashboard is here.
The Dashboard will continue to mature its data set, expand the funders captured, its countries represented and its scope to other areas of AMR R&D. Additional user-functionality will follow soon. In the coming months, further galleries of information will be added including product pipelines and incentives.
A user guide and background information of how the information was collected can be found here.
We thank all the organisations that have provided data and invite anyone who would like to submit data to contact us.
As of 27 March 2020 the Global AMR R&D Hub is on Twitter. If you would like to be informed on news and latest developments of the Global AMR R&D Hub you can follow us here.
10 March 2020: The Global AMR R&D Hub is delighted to announce its support for the expert team at Gesundheit Österreich GmbH (GÖG). GÖG will work together with 10 countries to explore existing health system tools which could be applied to new AMR-impacting technologies to improve the sustainability of the flow of new products for future generations. GÖG has an extensive global network and unique health system insights to conduct this work which we hope will begin to report by third quarter this year.